Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells

Takuya Fukazawa, Toshiyoshi Fujiwara, Futoshi Uno, Fuminori Teranishi, Yoshihiko Kadowaki, Takahiro Itoshima, Yoshiko Takata, Shunsuke Kagawa, Jack A. Roth, Jürg Tschopp, Noriaki Tanaka

Research output: Contribution to journalArticle

117 Citations (Scopus)

Abstract

Apoptosis is a morphologically distinct form of programmed cell death that plays a major role in cancer treatments. This cellular suicide program is known to be regulated by many different signals from both intracellular and extracellular stimuli. Here we report that p53 suppressed expression of the cellular FLICE-inhibitory protein (FLIP) that potentially blocks apoptotic signaling in human colon cancer cell lines expressing mutated and wild-type p53. In contrast, the expression of the death receptor KILLER/DR5 (TRAIL-R2) had no effect on FLIP expression, although exogenous p53 is known to induce KILLER/DR5 expression. In line with these observations, FLIP-negative cancer cells were sensitive to both p53- and KILLER/DRS-mediated apoptosis, whereas cells containing high levels of FLIP underwent apoptotic cell death when triggered by ectopic p53 expression but not by KILLER/DR5 expression. Treating the cells with a specific inhibitor of the proteasome inhibited the decrease of FLIP by p53, suggesting that p53 enhances the degradation of FLIP via a ubiquitin-proteasome pathway. Thus, the data indicate that p53-mediated downregulation of FLIP may explain the potent sensitization of human cancer cells to the apoptotic suicide program induced by wild-type p53 gene transler.

Original languageEnglish
Pages (from-to)5225-5231
Number of pages7
JournalOncogene
Volume20
Issue number37
DOIs
Publication statusPublished - Aug 23 2001

Fingerprint

CASP8 and FADD-Like Apoptosis Regulating Protein
Proteasome Endopeptidase Complex
Ubiquitin
Apoptosis
Neoplasms
Proteins
Suicide
Cell Death
Death Domain Receptors
Proteasome Inhibitors
p53 Genes
Colonic Neoplasms
Down-Regulation
Cell Line

Keywords

  • Apoptosis
  • Colon cancer
  • FLIP
  • P53
  • Ubiquitin-proteasome

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells. / Fukazawa, Takuya; Fujiwara, Toshiyoshi; Uno, Futoshi; Teranishi, Fuminori; Kadowaki, Yoshihiko; Itoshima, Takahiro; Takata, Yoshiko; Kagawa, Shunsuke; Roth, Jack A.; Tschopp, Jürg; Tanaka, Noriaki.

In: Oncogene, Vol. 20, No. 37, 23.08.2001, p. 5225-5231.

Research output: Contribution to journalArticle

Fukazawa, Takuya ; Fujiwara, Toshiyoshi ; Uno, Futoshi ; Teranishi, Fuminori ; Kadowaki, Yoshihiko ; Itoshima, Takahiro ; Takata, Yoshiko ; Kagawa, Shunsuke ; Roth, Jack A. ; Tschopp, Jürg ; Tanaka, Noriaki. / Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells. In: Oncogene. 2001 ; Vol. 20, No. 37. pp. 5225-5231.
@article{badf6a7f4ec341ac81a827e68c94897f,
title = "Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells",
abstract = "Apoptosis is a morphologically distinct form of programmed cell death that plays a major role in cancer treatments. This cellular suicide program is known to be regulated by many different signals from both intracellular and extracellular stimuli. Here we report that p53 suppressed expression of the cellular FLICE-inhibitory protein (FLIP) that potentially blocks apoptotic signaling in human colon cancer cell lines expressing mutated and wild-type p53. In contrast, the expression of the death receptor KILLER/DR5 (TRAIL-R2) had no effect on FLIP expression, although exogenous p53 is known to induce KILLER/DR5 expression. In line with these observations, FLIP-negative cancer cells were sensitive to both p53- and KILLER/DRS-mediated apoptosis, whereas cells containing high levels of FLIP underwent apoptotic cell death when triggered by ectopic p53 expression but not by KILLER/DR5 expression. Treating the cells with a specific inhibitor of the proteasome inhibited the decrease of FLIP by p53, suggesting that p53 enhances the degradation of FLIP via a ubiquitin-proteasome pathway. Thus, the data indicate that p53-mediated downregulation of FLIP may explain the potent sensitization of human cancer cells to the apoptotic suicide program induced by wild-type p53 gene transler.",
keywords = "Apoptosis, Colon cancer, FLIP, P53, Ubiquitin-proteasome",
author = "Takuya Fukazawa and Toshiyoshi Fujiwara and Futoshi Uno and Fuminori Teranishi and Yoshihiko Kadowaki and Takahiro Itoshima and Yoshiko Takata and Shunsuke Kagawa and Roth, {Jack A.} and J{\"u}rg Tschopp and Noriaki Tanaka",
year = "2001",
month = "8",
day = "23",
doi = "10.1038/sj.onc.1204673",
language = "English",
volume = "20",
pages = "5225--5231",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "37",

}

TY - JOUR

T1 - Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells

AU - Fukazawa, Takuya

AU - Fujiwara, Toshiyoshi

AU - Uno, Futoshi

AU - Teranishi, Fuminori

AU - Kadowaki, Yoshihiko

AU - Itoshima, Takahiro

AU - Takata, Yoshiko

AU - Kagawa, Shunsuke

AU - Roth, Jack A.

AU - Tschopp, Jürg

AU - Tanaka, Noriaki

PY - 2001/8/23

Y1 - 2001/8/23

N2 - Apoptosis is a morphologically distinct form of programmed cell death that plays a major role in cancer treatments. This cellular suicide program is known to be regulated by many different signals from both intracellular and extracellular stimuli. Here we report that p53 suppressed expression of the cellular FLICE-inhibitory protein (FLIP) that potentially blocks apoptotic signaling in human colon cancer cell lines expressing mutated and wild-type p53. In contrast, the expression of the death receptor KILLER/DR5 (TRAIL-R2) had no effect on FLIP expression, although exogenous p53 is known to induce KILLER/DR5 expression. In line with these observations, FLIP-negative cancer cells were sensitive to both p53- and KILLER/DRS-mediated apoptosis, whereas cells containing high levels of FLIP underwent apoptotic cell death when triggered by ectopic p53 expression but not by KILLER/DR5 expression. Treating the cells with a specific inhibitor of the proteasome inhibited the decrease of FLIP by p53, suggesting that p53 enhances the degradation of FLIP via a ubiquitin-proteasome pathway. Thus, the data indicate that p53-mediated downregulation of FLIP may explain the potent sensitization of human cancer cells to the apoptotic suicide program induced by wild-type p53 gene transler.

AB - Apoptosis is a morphologically distinct form of programmed cell death that plays a major role in cancer treatments. This cellular suicide program is known to be regulated by many different signals from both intracellular and extracellular stimuli. Here we report that p53 suppressed expression of the cellular FLICE-inhibitory protein (FLIP) that potentially blocks apoptotic signaling in human colon cancer cell lines expressing mutated and wild-type p53. In contrast, the expression of the death receptor KILLER/DR5 (TRAIL-R2) had no effect on FLIP expression, although exogenous p53 is known to induce KILLER/DR5 expression. In line with these observations, FLIP-negative cancer cells were sensitive to both p53- and KILLER/DRS-mediated apoptosis, whereas cells containing high levels of FLIP underwent apoptotic cell death when triggered by ectopic p53 expression but not by KILLER/DR5 expression. Treating the cells with a specific inhibitor of the proteasome inhibited the decrease of FLIP by p53, suggesting that p53 enhances the degradation of FLIP via a ubiquitin-proteasome pathway. Thus, the data indicate that p53-mediated downregulation of FLIP may explain the potent sensitization of human cancer cells to the apoptotic suicide program induced by wild-type p53 gene transler.

KW - Apoptosis

KW - Colon cancer

KW - FLIP

KW - P53

KW - Ubiquitin-proteasome

UR - http://www.scopus.com/inward/record.url?scp=17944373682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17944373682&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1204673

DO - 10.1038/sj.onc.1204673

M3 - Article

VL - 20

SP - 5225

EP - 5231

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 37

ER -